FDA's Advanced Manufacturing Technology Program: Accelerating The Drive To Integrated Automated Manufacturing

By David Shenberger, Vice President, Strategic Development

As part of an ongoing efforts to support the adoption of innovative manufacturing technologies, the FDA has introduced new Advanced Manufacturing Technologies (AMT) Designation program. The program is aimed at accelerating the implementation of these technologies to drive speed to patient and enhanced sustainability. The AMT designation is for mature technologies that have a strong basis in engineering and science with available performance data. Explore the key features of the AMT Program, the impact it could have on the pharmaceutical industry, and how manufacturers can engage with the program.